1. Position Paper: Personalised Medicine from a Health Economic Perspective - Lessons Learned and Potential Opportunities Ahead
- Author
-
Rutten-van Molken, Maureen, Versteegh, Matthijs, Huygens, Simone, Vellekoop, Heleen, Wordsworth, Sarah, Tsiachristas, Apostolos, Koleva-Kolarova, Rositsa, Nagy, Balazs, Zelei, Tamas, Szilberhorn, László, Ballensiefen, Wolfgang, Walgenbach, Maren, and Schartinger, Doris
- Subjects
cost effectiveness ,HEcoPerMed ,Personalised medicine ,health care modelling ,next-generation sequencing (NGS) ,health technology assessment (HTA) ,ToxNav ,Maturity Onset Diabetes of the Young (MODY) ,NTRK - Abstract
The HEcoPerMed project (Healthcare and pharma economics in support of the International Consortium for Personalised Medicine – ICPerMed) is a cooperation and support action (CSA) funded by the European Commission (EC). It is part of the socalled ICPerMed “family” of projects and initiatives that support the research and implementation of personalised medicine in Europe and beyond. This position paper discusses the contribution that economic evaluations can make to decisions surrounding the allocation of limited health care resources in personalised medicine (PM). In particular, the paper examines the role that health economic models can play in the context of Health Technology Assessment (HTA).
- Published
- 2022
- Full Text
- View/download PDF